Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
A Retrospective Cohort Study to Evaluate a Multigene assay to assess the recurrence risk of colorectal cancer.
应用场景：
创建时间：
2023-05-15
相关数据集
DataSheet_1_Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients.xlsx
IntroductionCirculating tumor DNA (ctDNA) has been increasingly recognized as a promising minimally-invasive biomarker that could identify patients with minimal residual disease and a high risk of rec
NIAID Data Ecosystem130
Table_1_Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment.doc
BackgroundStage II colorectal cancer(CRC) patients after surgery alone have a five-year survival rate of ~60-80%; the incremental benefit of adjuvant chemotherapy is <5%. Predicting risk of recurrence
NIAID Data Ecosystem80
DataSheet_1_Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment.pdf
BackgroundStage II colorectal cancer(CRC) patients after surgery alone have a five-year survival rate of ~60-80%; the incremental benefit of adjuvant chemotherapy is <5%. Predicting risk of recurrence
NIAID Data Ecosystem60
Supplementary Material for: Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories
Objective: Hereditary cancer testing guidelines are based on the premise that the common hereditary cancer syndromes have distinct, recognizable phenotypes. However, many syndromes prese
DataCite Commons2020-09-02 更新100
Genetic Markers in Patients With Colorectal Cancer
RATIONALE: Determination of genetic markers for colorectal cancer may improve the identification of patients who are at highest risk for relapse. PURPOSE: This clinical trial is studying the importanc
NIAID Data Ecosystem70
